AGP Limited is proud to be recognized as one of the ‘Top Exporter’ at the 7th Pharma Export Summit & Awards 2024.

AGP collaborates with Childlife Foundation on Children’s Day 2023

AGP Launched Peridots – A Thanda Solution to Acidity, Gas and Indigestion

AGP secures 2nd Position at BCR Awards 2022

AGP wins Top Exporter Award at 6th PPMA Summit

AGP sponsors KDSP Carnival 2023

AGP bags big win at GDEIB Awards 2023

AGP continues partnership with IBA

AGP continues collaboration with TCF

AGP joins hands with SKMF

AGP continues partnership with ACF

AGP conducts Allergy Awareness Session At Pak Turk Maarif

Gong-Ringing Ceremony of AGP at PSX

Home > Therapeutic Class > Antiobesity

Antiobesity

Abnil is indicated: – For obesity management including weight loss and weight maintenance when used in conjunction with a reduced-calorie diet. – To reduce the risk for weight regain after prior weight loss. – For obese patients with an initial body mass index (BMI) = 30 kg/m2 or = 27 kg/m2 in the presence of other risk factors (eg, hypertension, diabetes, dyslipidemia).